artificial intelligence
2022 Look Ahead
It's a seismic acquisition, one that was first floated more than 13 years ago. Now that it's finally happening (pending regulatory approval), observers assess the deal and offer thoughts on what's next.
After pioneering in stroke assessment, the investment will be directed to new therapeutic areas for lung fibrosis and cancer.
2022 Look Ahead
Sebastian Seiguer, CEO of the Johns Hopkins-backed emocha Health, offers a look forward to the lasting effects of the pandemic, and discusses the technology advancements he's looking forward to in 2022.
Lindera’s ‘SturzApp’ facilitates motion analysis via an app, using smartphone or tablet cameras to track movement and reduce the risk of falls in seniors.
Two of the world's top ten leading hospitals, from Sweden and Israel respectively, have signed a Memorandum of Understanding in a new collaborative partnership.
The companies said the technology will allow for earlier detection of breast cancer.
Also: Healthcare staffing company Hublo raises $25.5 million, insurtech startup Insurights rakes in $22 million.
The partnership will initially be used to distribute PathAI’s research-use-only algorithm focusing on immuno-oncology.
The latest approval marks DreaMed’s fourth clearance from the Food and Drug Administration.
Also: Corti.ai raises $27 million and DotCom Therapy scoops up $13 million.